PUBLIC DISCLOSURE & CLARIFICATION

BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.

CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.

5'-O-Acetyl-2',3'-dideoxy-2',3'-didehydro-5-fluoro-uridine

Inquiry

Cat. No.: X25-06-LY310

5'-O-Acetyl-2',3'-dideoxy-2',3'-didehydro-5-fluoro-uridine

Synonym: 160203-74-7; [(2S,5R)-5-(5-Fluoro-2,4-dioxopyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl acetate; [(2S,5R)-5-(5-Fluoro-2,4-dioxopyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl acetate; [(2S,5R)-5-(5-Fluoro-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl acetate; ((2S,5R)-5-(5-Fluoro-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dihydrofuran-2-yl)methyl acetate

CAS Number: 160203-74-7
Compound CID: 11076487

Product Size

50 mg; 100 mg; 250 mg; 500 mg

Price

Datasheet

MSDS

Properties

Description

5'-O-Acetyl-2',3'-dideoxy-2',3'-didehydro-5-fluoro-uridine is an improved uridine derivative with acetyl and fluorine substitutions.

Molecular Weight

270.21

Molecular Formula

C₁₁H₁₁FN₂O₅

Form

Solid

Purity

≥95.0%

Applications

5'-O-Acetyl-2',3'-dideoxy-2',3'-didehydro-5-fluoro-uridine can be used to study the properties of new nucleoside derivatives and explore their potential applications in nucleic acid chemistry.

Publications

Publications (0)

Publications

Publications

Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.

As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.

*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.